Lombard Odier & Cie (Canada)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-5,373
Closed -$177K 101
2015
Q1
$177K Hold
5,373
0.28% 62
2014
Q4
$159K Sell
5,373
-22,371
-81% -$641K 0.23% 66
2014
Q3
$778K Hold
27,744
0.5% 48
2014
Q2
$782K Sell
27,744
-4,137
-13% -$118K 0.51% 48
2014
Q1
$971K Hold
31,881
0.75% 37
2013
Q4
$926K Buy
+31,881
New +$928K 0.9% 30

Other funds holding PFE

Lombard Odier & Cie (Canada)'s PFE Position: Q2 2015 in Review

Lombard Odier & Cie (Canada) sold out of Pfizer (PFE) in Q2 2015, closing a stake of 5,373 shares — an estimated $177K sold.

Lombard Odier & Cie (Canada) first reported a position in PFE in Q4 2013 and held it in 6 quarters. The position peaked at $971K in Q1 2014. 1,887 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

  • Lombard Odier & Cie (Canada) reported no remaining Pfizer position as of Q2 2015 after selling out during the quarter.
  • Lombard Odier & Cie (Canada) sold 5,373 Pfizer shares in Q2 2015, an estimated $177K.
  • Lombard Odier & Cie (Canada) first reported a position in Pfizer in Q4 2013 and held it in 6 quarters.
  • Lombard Odier & Cie (Canada)'s Pfizer position peaked at $971K in Q1 2014.
  • 1,887 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on Lombard Odier & Cie (Canada)'s 13F filing for Q2 2015, filed 14 Aug 2015.